Literature DB >> 12218571

Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody.

Bahram R Oliai1, Hillel Kahane, Jonathan I Epstein.   

Abstract

Rare reports describe high molecular weight cytokeratin (clone 34betaE12) antibody cross-reactivity in scattered prostate carcinoma (PCa) cells, yet most often not in a true basal cell distribution. There are no data specifically describing 34betaE12 reactivity in basal cells in PCa. From August 10, 1995 to May 1, 2000, a total of 3198 consult prostate needle biopsies with PCa and a 34betaE12 immunoperoxidase stain were reviewed at our institution. Thirty-six cases (1.1%), which on hematoxylin and eosin stain were unequivocal cancer, had at least focal 34betaE12 positivity in a basal cell distribution. Twenty-five had original diagnostic slides for review. All cancers were Gleason score 6. The mean number of cancer glands per case was 36.9 (10-108) with an average of 39% of glands (1-100%) showing 34betaE12 reactivity. Twenty-one cases had patchy staining in a basal cell distribution with one other case showing continuous staining. An additional case showed mainly tumor cell reactivity with rare basal cell staining. The final two cases showed a zonal staining pattern with small glands toward one side of the lesion showing basal cells [one with high grade prostatic intraepithelial neoplasia (HGPIN); one without HGPIN]. HGPIN was present in 16 of 25 (64%) cases adjacent to PCa. The mean number of HGPIN glands was 1.36 (1-6). In cases with HGPIN the mean ratio of cancer to HGPIN glands was 6.8 (0.5-13.0). In 12 cases in which the lesion was still present on deeper sectioning, we were able to confirm in nine cases the presence of basal cells using antibodies to p63, another marker for prostatic basal cells. Four of the 25 men underwent radical prostatectomy; all showed Gleason score 6 PCa. Three radical prostatectomies demonstrated 34betaE12 reactivity: two with patchy staining in a basal cell distribution and one with mainly tumor cell staining. Adjacent HGPIN was present in all three radical prostatectomy specimens. Rare lesions with the appearance of PCa show 34betaE12 staining in a basal cell distribution either from retention of basal cells by early invasive cancer or from HGPIN outpouching. The lack of adjacent HGPIN in some cases and the large ratio of small atypical glands to HGPIN glands argue against HGPIN outpouching as the sole explanation. In cases with adjacent HGPIN a comparison of the proximity and number of the small, atypical, infiltrative appearing glands to HGPIN is helpful. The diagnosis of PCa in the face of positive 34betaE12 basal cell staining should be made with extreme caution, only in the face of unequivocal cancer on the hematoxylin and eosin stain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218571     DOI: 10.1097/00000478-200209000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

Review 1.  Histopathology reporting of prostate needle biopsies. 2005 update.

Authors:  Rodolfo Montironi; Remigio Vela Navarrete; Antonio Lopez-Beltran; Roberta Mazzucchelli; Gregor Mikuz; Aldo V Bono
Journal:  Virchows Arch       Date:  2006-04-22       Impact factor: 4.064

2.  Proliferative lesions of prostate: a multivariate approach to differential diagnosis.

Authors:  Fernanda de Barros Correia Cavalcanti; Venâncio Avancini Ferreira Alves; Julio Pereira; Cristina T Kanamura; Alda Wakamatsu; Luís Balthazar Saldanha
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  The significance of monoamine oxidase-A expression in high grade prostate cancer.

Authors:  Donna M Peehl; Marc Coram; Htet Khine; Stephen Reese; Rosalie Nolley; Hongjuan Zhao
Journal:  J Urol       Date:  2008-09-20       Impact factor: 7.450

4.  Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma.

Authors:  Bozo Kruslin; Davor Tomas; Aida Cviko; Hrvoje Cupic; Ljubica Odak; Mladen Belicza
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

Review 5.  Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Authors:  Murielle Mimeault; Parmender P Mehta; Ralph Hauke; Surinder K Batra
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

6.  Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.

Authors:  Alex Chang; Ali Amin; Edward Gabrielson; Peter Illei; Richard B Roden; Rajni Sharma; Jonathan I Epstein
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

Review 7.  Basaloid cell carcinoma of the prostate.

Authors:  Mauro G Mastropasqua; Giancarlo Pruneri; Giuseppe Renne; Ottavio De Cobelli; Giuseppe Viale
Journal:  Virchows Arch       Date:  2003-12       Impact factor: 4.064

Review 8.  Single foci prostate cancer: current diagnosis and management.

Authors:  Ioannis Efthimiou; Konstadinos Skrepetis; Elefteria Bournia
Journal:  Curr Urol       Date:  2013-07-28

9.  Aberrant cytoplasmic expression of p63 and prostate cancer mortality.

Authors:  Preet K Dhillon; Marc Barry; Meir J Stampfer; Sven Perner; Michelangelo Fiorentino; Alessandro Fornari; Jing Ma; Julia Fleet; Tobias Kurth; Mark A Rubin; Lorelei A Mucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01-20       Impact factor: 4.254

10.  Computer-aided detection of prostate cancer on tissue sections.

Authors:  Yahui Peng; Yulei Jiang; Shang-Tian Chuang; Ximing J Yang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.